Editorial Board for section 'Cancer Biology and Anticancer Therapeutics'

Please see the section webpage for more information on this section.

Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.

Members


Website
Section Editor-in-Chief
1. Department of Genomic Medicinal Science, Research Institute for Science and Technology, Organization for Research Advancement, Tokyo University of Science, Noda, Chiba 278-8510, Japan
2. Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan
Interests: apoptosis; NAD+ metabolism; poly(ADP-ribosyl)ation; post-translational modification; DNA replication; DNA repair; carcinogenesis; Warburg effect; neuro-inflammation; neuronal disorders; aging; transcription regulation; in silico drug design; AI medicine; anti-cancer drug; anti-inflammatory drug


Section Associate Editor
Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa 359-8513, Saitama, Japan
Interests: apoptosis; carcinogenesis; molecular oncology; signal transduction; MET; HGF/SF
Special Issues, Collections and Topics in MDPI journals


Section Board Member
Department of Life, Environment and Applied Chemistry, Faculty of Engineering, Fukuoka Institute of Technology (FIT), Fukuoka 811-0295, Japan
Interests: transcription factor; oncogene; ES cells; hematopoietic stem cells; leukemia; self-renewal; pluripotency

Website
Section Board Member
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
Interests: hepato-biliary-pancreatic cancers; risk factors; chemotherapy; targeted therapies; cancer treatment; precision medicine; microbiota
Special Issues, Collections and Topics in MDPI journals

grade Website
Section Board Member
Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Hong Kong, China
Interests: cancer biomarker; evidence-based medicine; extracellular vesicles; genomics; microRNA; molecular diagnostics; non-coding RNAs; nasopharyngeal carcinoma; next-generation sequencing; non-small cell lung cancer; proteomics; drug repurposing and bioinformatics
Special Issues, Collections and Topics in MDPI journals


Section Board Member
Division of Pharmacology and Toxicology, College of Pharmacy, Dell Pediatric Research Institute, University of Texas at Austin, Austin, TX 78705, USA
Interests: prostate cancer; cancer chemoprevention; phytochemicals and their combinations for cancer chemoprevention; obesity and dietary energy balance modulation on cancer; chemokines and cytokines on cancer; cancer microenvironment; amino acid degrading engineered enzymes as novel therapeutic target for treatment of cancer
Special Issues, Collections and Topics in MDPI journals


Section Board Member
Department of Clinical and Molecular Medicine, "Sapienza" University of Rome Sant'Andrea Hospital, 00128 Rome, Italy
Interests: lung cancer; liquid biopsy; personalized medicine; circulating tumor DNA; next generation sequencing; molecular target therapy
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Department for Life Quality Studies, Alma Mater Studiorum- University of Bologna, Corso d’Augusto 237, 47921 Rimini, Italy
Interests: in vitro anticancer activity; cytotoxicity; genotoxicity; cell culture; in vitro pharmacology; botanical drugs; gene expression; protein expression

Website
Section Board Member
Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-shi, Chiba-ken 278-8510, Japan
Interests: aging; cancer; cellular senesence; ETS family; GGAA motif; long non-coding RNA; neurodegenerative diseases; transcription; bi-directional promoters
Back to TopTop